Sort
85,873 grants matching “alzheimers”
BIOMEDICAL (BASIC)
$8,515,032Alfed Cheung · University Of Utah · N01 · FY2010 · HL
BIOMEDICAL (BASIC)
$8,511,177David C Goff · Wake Forest University Health Sciences · N01 · FY2010 · HL
ASPirin in Reducing Events in the Elderly - eXTension
$8,509,004Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2021 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,500,000Northern California Institute Res &Educ · U01 · FY2005 · AG
ARIC Neurocognitive Study (ARIC-NCS) Renewal
$8,485,666Josef Coresh · Johns Hopkins University · U01 · FY2021 · HL
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies
$8,479,107Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2023 · AG
Biospecimen Core
$8,427,609Bharat Thyagarajan · Washington University · U19 · FY2019 · AG
Indiana PROSPECT
$8,422,410Paul Dexter · Indiana University Indianapolis · R01 · FY2010 · HS
API A4 Alzheimer's Prevention Trial
$8,413,794Eric M Reiman · Banner Health · R01 · FY2022 · AG
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
$8,410,912Roberta Diaz Brinton · University Of Arizona · R01 · FY2019 · AG
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium
$8,370,718Timothy J Hohman · Vanderbilt University Medical Center · U24 · FY2025 · AG
ASPirin in Reducing Events in the Elderly - eXTension
$8,333,959Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2020 · AG
Asian Cohort for Alzheimer's Disease (ACAD)
$8,325,999Li-San Wang · University Of Pennsylvania · U19 · FY2023 · AG
TREAT AD
$8,324,233Allan I Levey · Emory University · U54 · FY2024 · AG
IUSM TREAT-AD Center
$8,323,362Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2025 · AG
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
$8,291,222Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U19 · FY2024 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)
$8,285,753Liana G Apostolova · Indiana University Indianapolis · U01 · FY2018 · AG
TREAT AD
$8,283,044Allan I Levey · Emory University · U54 · FY2025 · AG
A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of Alzheimer's disease
$8,272,985Ed Lein · Allen Institute · U19 · FY2021 · AG
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
$8,248,338Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U19 · FY2023 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,245,161Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2007 · AG
Metformin in Alzheimer's dementia Prevention (MAP)
$8,176,191Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2023 · AG
Alzheimer's Disease Neuroimaging Initiative
$8,143,896Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2011 · AG
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
$8,066,994John Alam · Eip Pharma, Inc. · R01 · FY2024 · AG
Asian Cohort for Alzheimer's Disease (ACAD)
$8,040,921Li-San Wang · University Of Pennsylvania · U19 · FY2024 · AG